Q4 2024 Management View CEO Richard Miller detailed the progress of soquelitinib, emphasizing its potential as a first-in-class oral therapy for immune diseases and cancers. He highlighted the 39% ...

More than 700 oncologists, cancer researchers and advocates will converge on the Crescent City this week as part of the 2025 NeauxCancer Conference. The event got its start four years ago by the ...

Finding God has been the answer for Olivia Anderson, 46, a Norfolkan who has been fighting an ongoing battle with lymphoma ...

Brunswick High School's "Brunswick for a Brighter Future" Student Visionaries team raised $168,000 for the Leukemia & ...

The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide.

The company behind Roundup weedkiller herbicide was ordered to pay more than $2 billion in a man’s cancer lawsuit. According to his attorneys, John Barnes developed non-Hodgkin’s lymphoma ...

Azercabtagene zapreleucel has been granted fast track designation from the FDA for the treatment of diffuse large B-cell ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...